Skip to main content
. 2019 May 6;6(6):ofz212. doi: 10.1093/ofid/ofz212

Table 1. .

Vaccine Virus Shedding, Peak Virus Titers, and Clinical Assessment During the First 28 Days After Inoculation

Viral Detectiona No. (%) With Indicated Symptomb
Group No. of Children No. (%) Shedding Vaccine Virusc Plaque Assay, Log10 PFU/mLd RT-qPCR, Log10 Copies/mLe Fever URI LRI Cough OM Respiratory or Febrile Illness
Vaccine 11 4 (36%) 1.6 (0.5–3.4) 4.5 (1.7–6.8) 2 (18) 6 (55) 2 (18) 4 (36) 3 (27) 7 (64)
Placebo 6 0 0.5 (0.5–0.5) 1.7 (1.7–1.7) 4 (67) 6 (100) 0 (0) 4 (67) 0 (0) 6 (100)

Abbreviations: LRI, lower respiratory illness, defined as wheezing, rhonchi, or rales, or having been diagnosed with pneumonia or laryngotracheobronchitis (croup); NW, nasal wash; OM, acute otitis media; PFU, plaque-forming unit; RT-qPCR, reverse transcription quantitative polymerase chain reaction; RSV, respiratory syncytial virus; URI, upper respiratory illness, defined as rhinorrhea, pharyngitis, or hoarseness.

aMedian (25th–75th percentile) peak viral titers detected in nasal washes. For the vaccine group, these summaries were calculated only for the 6 children who were infected with vaccine virus; infection was defined as the detection of vaccine virus by culture and/or RT-qPCR and/or a ≥4-fold rise in RSV serum-neutralizing antibody titer and/or serum anti-RSV F antibody titer. As expected, no placebo recipients shed vaccine virus.

bNumber (%) of children with indicated respiratory symptoms occurring in the 28 days after inoculation.

cPercentage of children with vaccine virus detected in NW by culture and/or RT-qPCR. Three children had vaccine virus detected by both culture and PCR, and 1 only by RT-qPCR.

dFor each child, the individual peak (highest) titer, irrespective of day, was selected from among all titers measured in the NW by viral culture and expressed as log10 PFU/mL. The lower limit of detection was 0.5 log10 PFU/mL.

eFor each participant, the individual peak (highest) titer, irrespective of day, was selected from among all titers measured in NW by RT-qPCR and expressed as log10 copies/mL. The lower limit of detection was 1.7 log10 copies/mL.